BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 34848258)

  • 1. Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder.
    Fromme M; Schneider CV; Trautwein C; Brunetti-Pierri N; Strnad P
    J Hepatol; 2022 Apr; 76(4):946-958. PubMed ID: 34848258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.
    Schneider CV; Hamesch K; Gross A; Mandorfer M; Moeller LS; Pereira V; Pons M; Kuca P; Reichert MC; Benini F; Burbaum B; Voss J; Gutberlet M; Woditsch V; Lindhauer C; Fromme M; Kümpers J; Bewersdorf L; Schaefer B; Eslam M; Bals R; Janciauskiene S; Carvão J; Neureiter D; Zhou B; Wöran K; Bantel H; Geier A; Dirrichs T; Stickel F; Teumer A; Verbeek J; Nevens F; Govaere O; Krawczyk M; Roskams T; Haybaeck J; Lurje G; Chorostowska-Wynimko J; Genesca J; Reiberger T; Lammert F; Krag A; George J; Anstee QM; Trauner M; Datz C; Gaisa NT; Denk H; Trautwein C; Aigner E; Strnad P;
    Gastroenterology; 2020 Aug; 159(2):534-548.e11. PubMed ID: 32376409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation.
    Hamesch K; Mandorfer M; Pereira VM; Moeller LS; Pons M; Dolman GE; Reichert MC; Schneider CV; Woditsch V; Voss J; Lindhauer C; Fromme M; Spivak I; Guldiken N; Zhou B; Arslanow A; Schaefer B; Zoller H; Aigner E; Reiberger T; Wetzel M; Siegmund B; Simões C; Gaspar R; Maia L; Costa D; Bento-Miranda M; van Helden J; Yagmur E; Bzdok D; Stolk J; Gleiber W; Knipel V; Windisch W; Mahadeva R; Bals R; Koczulla R; Barrecheguren M; Miravitlles M; Janciauskiene S; Stickel F; Lammert F; Liberal R; Genesca J; Griffiths WJ; Trauner M; Krag A; Trautwein C; Strnad P;
    Gastroenterology; 2019 Sep; 157(3):705-719.e18. PubMed ID: 31121167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Lipid Profiling Reveals Major Differences between Liver Organoids with Normal Pi*M and Deficient Pi*Z Variants of Alpha-1-antitrypsin.
    Pérez-Luz S; Lalchandani J; Matamala N; Barrero MJ; Gil-Martín S; Saz SR; Varona S; Monzón S; Cuesta I; Justo I; Marcacuzco A; Hierro L; Garfia C; Gomez-Mariano G; Janciauskiene S; Martínez-Delgado B
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency.
    Ruiz M; Lacaille F; Schrader C; Pons M; Socha P; Krag A; Sturm E; Bouchecareilh M; Strnad P
    Semin Liver Dis; 2023 Aug; 43(3):258-266. PubMed ID: 37402396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ).
    Fromme M; Hamesch K; Schneider CV; Mandorfer M; Pons M; Thorhauge KH; Pereira V; Sperl J; Frankova S; Reichert MC; Benini F; Burbaum B; Kleinjans M; Amzou S; Rademacher L; Bewersdorf L; Verbeek J; Nevens F; Genesca J; Miravitlles M; Nuñez A; Schaefer B; Zoller H; Janciauskiene S; Waern J; Oliveira A; Maia L; Simões C; Mahadeva R; Fraughen DD; Trauner M; Krag A; Lammert F; Bals R; Gaisa NT; Aigner E; Griffiths WJ; Denk H; Teumer A; McElvaney NG; Turner AM; Trautwein C; Strnad P
    Clin Gastroenterol Hepatol; 2024 Feb; 22(2):283-294.e5. PubMed ID: 37716616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients.
    Turner AM; Stolk J; Bals R; Lickliter JD; Hamilton J; Christianson DR; Given BD; Burdon JG; Loomba R; Stoller JK; Teckman JH
    J Hepatol; 2018 Aug; 69(2):378-384. PubMed ID: 29572094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary alpha-1-antitrypsin deficiency and its clinical consequences.
    Fregonese L; Stolk J
    Orphanet J Rare Dis; 2008 Jun; 3():16. PubMed ID: 18565211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity.
    Laffranchi M; Berardelli R; Ronzoni R; Lomas DA; Fra A
    Hum Mol Genet; 2018 May; 27(10):1785-1793. PubMed ID: 29538751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of children with α-1 antitrypsin deficiency.
    Comba A; Demirbaş F; Çaltepe G; Eren E; Kalayci AG
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):774-778. PubMed ID: 29505478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleaning up alpha-1 antitrypsin deficiency related liver disease.
    Rademacher L; Fromme M; Strnad P
    Curr Opin Gastroenterol; 2023 May; 39(3):163-168. PubMed ID: 37144533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alpha-1 antitrypsin deficiency: cause and cofactor for liver disease].
    Burbaum B; Fromme M; Strnad P
    Dtsch Med Wochenschr; 2021 Jun; 146(11):714-718. PubMed ID: 34062584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort.
    Clark VC; Marek G; Liu C; Collinsworth A; Shuster J; Kurtz T; Nolte J; Brantly M
    J Hepatol; 2018 Dec; 69(6):1357-1364. PubMed ID: 30138687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis.
    Al-Jameil N; Hassan AA; Buhairan A; Hassanato R; Isac SR; Al-Otaiby M; Al-Maarik B; Al-Ajeyan I
    Medicine (Baltimore); 2017 Feb; 96(6):e6071. PubMed ID: 28178162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
    Barjaktarevic I; Miravitlles M
    BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-1-antitrypsin phenotypes in adult liver disease patients.
    Topic A; Alempijevic T; Milutinovic AS; Kovacevic N
    Ups J Med Sci; 2009; 114(4):228-34. PubMed ID: 19961268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.
    Teckman JH
    COPD; 2013 Mar; 10 Suppl 1():35-43. PubMed ID: 23527737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency.
    Fromme M; Schneider CV; Pereira V; Hamesch K; Pons M; Reichert MC; Benini F; Ellis P; H Thorhauge K; Mandorfer M; Burbaum B; Woditsch V; Chorostowska-Wynimko J; Verbeek J; Nevens F; Genesca J; Miravitlles M; Nuñez A; Schaefer B; Zoller H; Janciauskiene S; Abreu N; Jasmins L; Gaspar R; Liberal R; Macedo G; Mahadeva R; Gomes C; Schneider KM; Trauner M; Krag A; Gooptu B; Thorburn D; Marshall A; Hurst JR; Lomas DA; Lammert F; Gaisa NT; Clark V; Griffiths W; Trautwein C; Turner AM; McElvaney NG; Strnad P
    Gut; 2022 Feb; 71(2):415-423. PubMed ID: 33632708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha1-antitrypsin deficiency: New therapies on the horizon.
    Remih K; Amzou S; Strnad P
    Curr Opin Pharmacol; 2021 Aug; 59():149-156. PubMed ID: 34256305
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.